David Castle
机构:University of Tasmania, Mental Health Australia · ORCID:0000-0002-3075-1580
发表论文 1217 篇 · 总被引 43554 次 · h-index 91
代表论文
- The Use of Long-Acting Injectables for People with Schizophrenia: Consensus Panel Recommendations for Overcoming Barriers and Implementing Treatment (2025 · Neurology and Therapy · 被引 9)
- Disease relapse, all-cause mortality, and adverse events associated with long-acting injectable antipsychotics versus oral antipsychotics in older people with schizophrenia in Hong Kong: a population-based within-subject analysis (2025 · The Lancet Psychiatry · 被引 5)
- Psilocybin with psychotherapeutic support for treatment-resistant depression: a pilot clinical trial (2025 · Therapeutic Advances in Psychopharmacology · 被引 5)
- Psilocybin-assisted psychotherapy for treatment-resistant obsessive–compulsive disorder: protocol for an open-label pilot study (2025 · BJPsych Open · 被引 3)
- A multisite study of the overlap between symptoms and cognition in schizophrenia: Une étude multicentrique sur le chevauchement entre les symptômes et les troubles cognitifs chez les personnes atteintes de schizophrénie (2025 · The Canadian Journal of Psychiatry · 被引 3)
- A Multi-Symptom Circuit Architecture of Obsessive–Compulsive Disorder (2025 · medRxiv · 被引 1)